Colorectal cancer screening - using informatics and compunetics to empower the at-risk individual.

Stud Health Technol Inform

Scientific Technologies Corporation, Canada.

Published: September 2008

Population-based cancer screening is most effective and cost efficient when offered through an organized screening program that incorporates all elements of the screening process, including information systems that support optimal program operation, monitoring, and evaluation. Although it is well accepted that organized population-based cancer screening programs can effectively reduce mortality, little effort has been invested in designing, developing, and implementing information systems to support these programs. This paper presents a prototype information management system for organized population-based cancer screening. A typical colorectal cancer screening program was modeled for illustration of organized cancer screening workflow, key functional features were investigated, and a system infrastructure and architecture designed. The system as designed facilitates the sharing and management of information among the many stakeholders involved in the program (e.g., participant, family physician, specialist, hospitals, laboratories pharmacist). Throughout the functional design phase of this project, empowerment of the-at risk individual with access to personalized information and support was the core consideration. The leveraging of existing health records to facilitate risk profiling, and the proactive engagement and education of individuals with personalized information were considered key functional requirements of the system. The system was designed to provide participants with easy web-enabled access to view their status in the cancer screening program, and on-line resources to facilitate scheduling of activities, updating of personal profiles, and access to additional relevant information. By proactively engaging individuals, providing them with personalized information, and facilitating their involvement in the cancer screening program with easy-to-use information management tools, the likelihood of program enrollment and participation will be greatly increased.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cancer screening
32
screening program
16
population-based cancer
12
screening
10
colorectal cancer
8
systems support
8
organized population-based
8
key functional
8
system designed
8
cancer
7

Similar Publications

Liver cancer poses a global health challenge with limited therapeutic options. Notably, the limited success of current therapies in patients with primary liver cancers (PLCs) may be attributed to the high heterogeneity of both hepatocellular carcinoma (HCCs) and intrahepatic cholangiocarcinoma (iCCAs). This heterogeneity evolves over time as tumor-initiating stem cells, or cancer stem cells (CSCs), undergo (epi)genetic alterations or encounter microenvironmental changes within the tumor microenvironment.

View Article and Find Full Text PDF

Background: Immunosuppression might increase the risk of skin cancer in organ transplant recipients (OTRs), with azathioprine (AZA), exerting a fundamental role in the carcinogenesis of those tumors. This systematic review and meta-analysis aims to address the risk of developing malignant skin neoplasms in OTRs undergoing immunosuppression with AZA.

Methods: PubMed, Cochrane and Embase were searched for studies with OTRs who have a treatment regimen involving Azathioprine therapy after transplantation and that analyzed the emergence of skin neoplasia.

View Article and Find Full Text PDF

Design, synthesis, and in vitro antitumor evaluation of novel benzimidazole acylhydrazone derivatives.

Mol Divers

January 2025

State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals of Guizhou University, Guiyang, Guizhou, 550025, People's Republic of China.

This study focuses on the design, synthesis, and evaluation of benzimidazole derivatives for their anti-tumor activity against A549 and PC-3 cells. Initial screening using the MTT assay identified compound 5m as the most potent inhibitor of A549 cells with an IC of 7.19 μM, which was superior to the positive agents 5-Fluorouracil and Gefitinib.

View Article and Find Full Text PDF

Globally, the incidence and death rates associated with cancer persist in rising, despite considerable advancements in cancer therapy. Although some malignancies are manageable by a mix of chemotherapy, surgery, radiation, and targeted therapy, most malignant tumors either exhibit poor responsiveness to early identification or endure post-treatment survival. The prognosis for prostate cancer (PCa) is unfavorable since it is a perilous and lethal malignancy.

View Article and Find Full Text PDF

Background: Novel colorectal cancer endoscopic surveillance techniques for inflammatory bowel disease (IBD) have recently been developed.

Aims: Compare the efficacy of currently available techniques for dysplasia detection in colonic IBD.

Methods: We conducted a systematic literature search from inception to March 2024 for randomized controlled trials (RCTs) or prospective cohort studies enrolling adults with IBD and having surveillance colonoscopy for dysplasia screening.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!